Binyuan Yan

5PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 14, 2026
Evaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.

|Jul 07, 2025
DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers.

Rui Sun, Peng Jiang, Zhijun Wang

|Aug 01, 2023
Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis.

Rui Sun, Binyuan Yan, Hao Li

|Jan 13, 2023
SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors.

Zhenlin Huang, Xiang Li, Bo Tang

|Jun 23, 2021
MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression.

Zhenlin Huang, Bo Tang, Yinhui Yang

Pageof 1

Frequent Collaborators

4 joint publications

Haojie Huang

3 joint publications

Liguo Wang

2 joint publications

Hao Li

2 joint publications

Rui Sun